The molecular characterization of disseminated tumor cells and circulating tumor cells opens a new avenue for understanding cancer dormancy and might contribute to the identification of metastatic stem cells with important implications for future therapies. This Review focuses on the clinical relevance of the latest research results on blood-borne cancer micrometastasis in patients with cancer.
- Klaus Pantel
- Catherine Alix-Panabières
- Sabine Riethdorf
